Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

AMRX Price Correlated With Financials For Amneal Pharmaceuticals

See how revenue, income, cash flow, and balance sheet financials have changed over 14 quarters since 2018. Compare with AMRX stock chart to see long term trends.

AMRX Stock Compared to Quarterly

AMRX Income Statement

Revenue, Net:528593000
Cost of Goods & Services Sold:329394000
Gross Profit:198511000
Selling, General & Admin Expense:91397000
Research & Development Expense:48927000
Operating Income:28515000
Income Taxes:4049000
Net Income:-7783000
Earnings Per Share, Basic:-0.03
Shares Outstanding, Basic Avg:149290000
Revenue Per Share:3.5407

AMRX Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:-24061000
Net Cash from Operations:82364000
Net Cash from Operations Per Share:0.5517
Net Cash from Financing Activities:-43555000
Property, Plant & Equipment Purchases:10645000
Purchases of Businesses, Net of Cash:0
Net Cash from Investing Activities:-11633000
Net Change in Cash & Equivalents:27466000

AMRX Balance Sheet

Cash and Cash Equivalents:310619000
Accounts Receivable, Net:627954000
Inventories:520245000
Total Current Assets:1570337000
Property, Plant & Equipment, Net:459651000
Total Assets:3974409000
Accounts Payable:null
Current Portion of Long-Term Debt:30471000
Total Short-Term Liabilities:667335000
Long Term Debt, Non-Current Portion:2687668000

Insider Trading

Change
Value
Transaction
SEC Form 4
Patel Gautam   Director
50,000 sh at $4
$210,500
Buy
Patel Chintu   Co-CEO
150,000 sh at $4
$625,500
Buy
Patel Chirag K.   President & Co-CEO
150,000 sh at $4
$625,500
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Fosun International Ltd
21,521,301 sh
 
$114,924
TPG Group Holdings (Sbs) Advisors, Inc.
16,213,367 sh
 
$86,579
Vanguard Group Inc
11,259,859 sh
-236,808 sh
-2%
$60,128
$1,265
Blackrock Inc.
6,946,889 sh
-146,938 sh
-2%
$37,095
$773
Eversept Partners, Lp
6,849,834 sh
1,225,109 sh
22%
$36,578
$7,779
Point72 Asset Management, L.P.
3,745,000 sh
1,920,196 sh
105%
$19,998
$10,655
Neuberger Berman Group LLC
3,312,174 sh
-53,907 sh
-2%
$17,473
$328
State Street Corp
2,529,797 sh
-209,018 sh
-8%
$13,509
-$514
Jacobs Levy Equity Management, Inc
1,882,186 sh
-217,748 sh
-10%
$10,051
-$701
Nuveen Asset Management, LLC
1,695,568 sh
-528,577 sh
-24%
$8,562
-$2,826
Geode Capital Management, LLC
1,619,999 sh
-262,711 sh
-14%
$8,650
-$989
Lsv Asset Management
1,545,600 sh
 
$8,253
Dimensional Fund Advisors LP
1,342,392 sh
-42,041 sh
-3%
$7,170
$81
Citadel Advisors LLC
1,160,907 sh
1,112,907 sh
2319%
$6,199
$5,953
Northern Trust Corp
1,147,242 sh
-49,738 sh
-4%
$6,126
-$2
Charles Schwab Investment Management Inc
1,146,263 sh
49,813 sh
5%
$6,122
$508
Victory Capital Management Inc
1,009,633 sh
-911,857 sh
-47%
$5,392
-$4,446
Goldman Sachs Group Inc
940,630 sh
255,551 sh
37%
$5,023
$1,515
Millennium Management LLC
877,304 sh
54,040 sh
7%
$4,685
$470
Hillsdale Investment Management Inc.
872,516 sh
85,700 sh
11%
$4,659
$630

Data imported from Amneal Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.